Evidence map›Paper›PMID 34413382›Full record

ArticleScientific reports2021

Plasma fibrinogen, D-dimer, and fibrin degradation product as biomarkers of rheumatoid arthritis.

Li Xue, Li Tao, Xueyi Li, Yan Wang, Biao Wang, Yanping Zhang, Ning Gao, Yanying Dong, Nan Xu, Chaoliang Xiong and 7 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Li XueDepartment of Clinical Laboratory, The Second Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an, 710004, China.
Li TaoDepartment of Clinical Laboratory, The Second Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an, 710004, China.
Xueyi LiDepartment of Rheumatology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China.
Yan WangDepartment of Clinical Laboratory, The Second Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an, 710004, China.
Biao WangDepartment of Immunology and Pathogenic Biology, Health Science Center, Xi'an Jiaotong University, Xi'an, 710061, China.
Yanping ZhangDepartment of Clinical Laboratory, The Second Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an, 710004, China.
Ning GaoDepartment of Clinical Laboratory, The Second Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an, 710004, China.
Yanying DongDepartment of Clinical Laboratory, The Second Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an, 710004, China.
Nan XuDepartment of Clinical Laboratory, The Second Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an, 710004, China.
Chaoliang XiongDepartment of Clinical Laboratory, The Second Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an, 710004, China.
Ting ZhouDepartment of Clinical Laboratory, The Second Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an, 710004, China.
Zeshi LiuDepartment of Clinical Laboratory, The Second Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an, 710004, China.
Hailong LiuDepartment of Clinical Laboratory, The Second Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an, 710004, China.
Juntao HeDepartment of Clinical Laboratory, The Second Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an, 710004, China.
Ke LiCore Research Laboratory, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. ke.li@mail.xjtu.edu.cn.
Yan GengDepartment of Clinical Laboratory, The Second Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an, 710004, China. gengyanjyk@126.com.
Ming LiDepartment of Cardiovascular Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China. minglil@126.com.
Second Affiliated Hospital of Xi'an Jiaotong University · CNFirst Affiliated Hospital of Xi'an Jiaotong University · CNXi'an Jiaotong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to assess the association of coagulation-related indicators such as plasma fibrinogen (FIB), D-dimer, and fibrin degradation product (FDP) in rheumatoid arthritis (RA) with the disease activity. Data from 105 RA patients and 102 age- and gender-matched healthy controls were collected in the retrospective study. Disease activity score in 28 joints based on C-reactive protein (DAS28-CRP) was used to divide RA patients into low activity group (DAS28-CRP ≤ 2.7) and active group (DAS28-CRP > 2.7). Receiver operating characteristic (ROC) curve was applied to determine area under the curve (AUC). The association between plasma FIB, D-dimer, and FDP and DAS28-CRP was evaluated by spearman correlation. Logistical regression analysis was used to identify the independent variables associated with RA disease activity. RA patients showed higher levels of plasma FIB, D-dimer, and FDP than the controls (P < 0.01). Plasma FIB, D-dimer, and FDP were also increased in active groups of RA patients than those in inactive groups (P < 0.001). ROC curve analyses revealed that the AUC of D-dimer was higher than erythrocyte sedimentation rate (ESR) and rheumatoid factor (RF), and that of FDP was higher than RF in RA patients. In addition, the optimal cut-off value of plasma FIB, D-dimer, and FDP for RA diagnosis was 286 mg/dL, 470 μg/L, and 1.45 mg/L, respectively. Spearman analysis showed that plasma FIB, D-dimer, and FDP were positively related with DAS28-CRP (P < 0.001) in RA patients. Logistical regression analysis showed that D-dimer (odds ratio 2.862, 95% confidence interval 1.851-5.426, P < 0.001) was an independent variable associated with RA disease activity. FIB, D-dimer, and FDP were increased in RA patients and positively correlated with the disease activity of RA. D-dimer may act as a novel inflammatory indice for indicating disease activity in RA patients.

Indexed as

Arthritis, RheumatoidBiomarkersBlood CoagulationCase-Control StudiesFemaleFibrin Fibrinogen Degradation ProductsFibrinogenHumansLogistic ModelsMaleMiddle AgedROC CurveBiomarkersFibrin Fibrinogen Degradation Productsfibrin fragment DFibrinogen

Identifiers

PMID34413382
PMCPMC8377052
OpenAlexW3164140140

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.